Table 1.
Author/year | Country | Types of TB | Type of article | Nature of study | Adult | IGRA | TB patients | All patients |
---|---|---|---|---|---|---|---|---|
Aabye 2009 | Tanzania | AT | FA | Retro | Adult | QFT-GIT | 161 | 161 |
Adams 2019 | South Africa | LTBI | FA | Retro | Adult | Q&T | 496 | 496 |
Cai 2014 | China | AT | FA | Retro | Adult | T-SPOT | 100 | 100 |
Cattamanchi 2010 | USA | AT | FA | pros | Adult | T-SPOT | 112 | 212 |
Chee 2008 | Singapore | AT | FA | retro | Adult | Q&T | 280 | 280 |
Chen 2011 | China | AT | FA | pros | Adult | T-SPOT | 38 | 147 |
Clark 2007 | UK | AT | FA | pros | Adult | T-SPOT | 30 | 30 |
Davies 2009 | South Africa | AT | FA | pros | Children | T-SPOT | 60 | 109 |
Dheda 2009 | South Africa | AT | FA | pros | Adult | Q&T | 20 | 20 |
Elzi 2011 | Switzerland | LTBI | FA | pros | Adult | T-SPOT | 64 | 64 |
Fujita 2011 | Japan | AT | FA | pros | Adult | QFT-GIT | 9 | 107 |
Garcia-Gasalla 2013 | Spain | AT | FA | pros | Adult | QFT-GIT | 118 | 118 |
Hormi 2018 | France | AT | FA | pros | Children | QFT-GIT | 24 | 24 |
Idh 2010 | Sweden | AT | FA | pros | Adult | QFT-GIT | 69 | 69 |
Jiang 2009 | China | AT<BI | FA | pros | Adult | T-SPOT | 100 | 100 |
Jonnalagadda 2013 | USA | AT | FA | retro | Adult(W) | T-SPOT | 9 | 9 |
Kabeer 2011 | India | AT | FA | pros | Adult | QFT-GIT | 105 | 105 |
Kaswandani 2018 | Indonesia | TB | CA | retro | Children | QFT-GIT | 10 | 10 |
Khawcharoenporn 2015 | Thailand | LTBI | FA | pros | Adult | QFT-GIT | 36 | 36 |
Klautau 2018 | Brazil | LTBI | FA | retro | Adult | QFT-GIT | 84 | 84 |
Kussen 2016 | Brazil | LTBI | FA | pros | Adult | QFT-GIT | 25 | 25 |
LaCourse 2017 | USA | AT | FA | pros | Adult (W) | QFT-GIT | 100 | 100 |
Lavender 2011 | UK | AT | CA | retro | Adult | QFT-GIT | 66 | 326 |
Lee 2019 | Korea | TB | FA | pros | Adult | T-SPOT | 25 | 62 |
Legesse 2010 | Ethiopia | AT | FA | pros | Adult | QFT-GIT | 50 | 50 |
Leidl 2010 | Uganda | AT | FA | retro | Adult | Q&T | 19 | 19 |
ling 2011 | Canada | AT | FA | pros | Adult | Q&T | 127 | 127 |
Lundtoft 2017 | Ghana | AT | FA | pros | Children | QFT-GIT | 25 | 25 |
Markova 2009 | Bulgaria | AT | FA | pros | Adult | Q&T | 13 | 90 |
Oni 2010 | UK | AT | FA | pros | Adult | T-SPOT | 85 | 85 |
Petruccioli 2020 | Italy | AT | FA | pros | Adult | QFT-plus | 32 | 32 |
Pettit 2020 | USA | LTBI | FA | pros | All | Q&T | 81 | 1520 |
Raby 2008 | Zambia | AT | FA | pros | Adult | QFT-GIT | 96 | 96 |
Rangaka 2012 | South Africa | LTBI | FA | pros | Adult | QFT-GIT | 50 | 50 |
Sanogo 2020 | Burkina | AT | FA | pros | Children | QFT-GIT | 29 | 58 |
Sattah 2012 | USA | AT | CA | retro | Adult | T-SPOT | 9 | 9 |
Sauzullo 2010 | Italy | AT | FA | pros | Adult | QFT-GIT | 30 | 194 |
Sauzullo 2014 | Italy | AT | FA | pros | Adult | QFT-GIT | 44 | 44 |
Stavri 2009 | Romania | AT | FA | pros | All | QFT-GIT | 36 | 36 |
Takwoingi 2019 | UK | AT | FA | retro | Adult | Q&T | 385 | 911 |
Tsiouris 2006 | South Africa | AT | FA | pros | Adult | QFT-GIT | 36 | 36 |
Vanini 2012 | Italy | AT | FA | pros | Adult | QFT-GIT | 58 | 58 |
Veldsman 2009 | South Africa | AT | FA | pros | Adult | QFT-GIT | 30 | 60 |
Vincenti 2007 | India | AT | FA | pros | Adult | Q&T | 45 | 111 |
Yu 2013 | China | AT | FA | pros | Adult | T-SPOT | 46 | 120 |
TB tuberculosis disease, AT active TB; LTBI latent tuberculosis infection; IGRA interferon-gamma release assay, QFT-GIT QuantiFERON-TB-Gold In-Tube, T-SPOT T-SPOT.TB, Q&T QuantiFERON-TB-Gold In-Tube and T-SPOT.TB